相关实验视频
Updated: Jun 7, 2025

06:17
Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
24.1K
准内质网膜压力诱导的淋巴功能障碍,以减轻与双酸相关的骨髓缩
Ziyue Qin1,2, Hanyu Xie1,2, Pengcheng Su1,2
1Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China.
Clinical and translational medicine
|November 9, 2024
概括
与双酸盐相关的下巴骨 necrosis (BRONJ) 涉及淋巴排水受损. 索莱德酸会引起淋巴细胞内质网膜应激和亡,但一种新的纳米粒子疗法恢复了淋巴功能并减轻了BRONJ.
科学领域:
- 生物医学研究的研究.
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 双酸盐 (BPs) 对于治疗骨质再吸收障碍至关重要.
- 双酸盐相关的骨亡 (BRONJ) 是一种严重的并发症,其特征是炎症和骨亡.
- 淋巴疏通障碍在BRONJ病变发生中的作用尚不清楚.
研究的目的:
- 为了研究受损淋巴排水对BRONJ的影响.
- 阐明勒酸 (ZA) 诱导的淋巴内皮细胞 (LEC) 损伤背后的机制.
- 评估一种新的纳米粒子疗法,以缓解BRONJ.
主要方法:
- 建立了BRONJ的小鼠模型来评估淋巴功能.
- 使用了组织清除,淋巴清除测定,流细胞计和组织病理学.
- 采用RNA测序,代谢学,电子显微镜和西方涂抹来分析ZA对LEC的影响.
- 生成了条件淘汰赛小鼠来研究SIRT6和ATG5.5的作用.
- 开发并测试了纳米粒子载荷的ZA和拉巴胺素 (ZDPR) 用于BRONJ处理.
主要成果:
- 青铜模型表现出淋巴疏通受损,炎症和骨亡.
- ZA诱导了内等质网膜应激 (ERS) 和抑制了LEC中的自,导致了亡.
- ZA激活了NAD+/SIRT6/XBP1s通路,导致LEC中的ERS诱导的亡.
- 删除SIRT6或ATG5在BRONJ中加剧了淋巴功能障碍和炎症.
- ZDPR纳米颗粒减轻了LEC中的ERS-亡,改善了淋巴功能,解决了炎症.
结论:
- 在ZA治疗的LEC中,NAD+/SIRT6/XBP1s通路调解了ERS诱导的亡.
- 淋巴排水障碍加剧了.
- ZDPR纳米颗粒通过恢复内皮功能和淋巴排水来显示治疗潜力,有效地减轻BRONJ.
相关概念视频
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K

